Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients (Frontiers in Immunology, (2023), 14, (1188818), 10.3389/fimmu.2023.1188818)

  1. Jiménez-Ubieto, A.
  2. Martín-Muñoz, A.
  3. Poza, M.
  4. Dorado, S.
  5. García-Ortiz, A.
  6. Revilla, E.
  7. Sarandeses, P.
  8. Ruiz-Heredia, Y.
  9. Baumann, T.
  10. Rodríguez, A.
  11. Calbacho, M.
  12. Sánchez, P.M.
  13. Pina, J.M.S.
  14. García-Sancho, A.M.
  15. Figaredo, G.
  16. Rufián, L.
  17. Rodríguez, M.
  18. Carneros, L.
  19. Martínez-Laperche, C.
  20. Bastos-Oreiro, M.
  21. Wang, C.
  22. Cedena, M.-T.
  23. Rapado, I.
  24. de Toledo, P.
  25. Gallardo, M.
  26. Valeri, A.
  27. Ayala, R.
  28. Martínez-López, J.
  29. Barrio, S.
  30. Show all authors +
Journal:
Frontiers in Immunology

ISSN: 1664-3224

Year of publication: 2023

Volume: 14

Type: Erratum

DOI: 10.3389/FIMMU.2023.1243241 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus